Literature DB >> 30182292

Sclerostin: a biomarker for chronic kidney disease and vascular disease with added or independent value?

Marijan Bosevski1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30182292     DOI: 10.1007/s11255-018-1972-0

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


× No keyword cloud information.
  8 in total

Review 1.  Carotid artery disease in diabetic patients.

Authors:  Marijan Bosevski
Journal:  Pril (Makedon Akad Nauk Umet Odd Med Nauki)       Date:  2014

2.  Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects. Results from a cross-sectional study in Malmö, Sweden.

Authors:  B Hedblad; P Nilsson; L Janzon; G Berglund
Journal:  Diabet Med       Date:  2000-04       Impact factor: 4.359

3.  Is serum sclerostin a marker of atherosclerosis in patients with chronic kidney disease-mineral and bone disorder?

Authors:  Andreja Figurek; Goce Spasovski
Journal:  Int Urol Nephrol       Date:  2018-07-20       Impact factor: 2.370

Review 4.  Sclerostin, cardiovascular disease and mortality: a systematic review and meta-analysis.

Authors:  Mehmet Kanbay; Yalcin Solak; Dimitrie Siriopol; Gamze Aslan; Baris Afsar; Dilek Yazici; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2016-08-06       Impact factor: 2.370

5.  Sclerostin levels in uremic patients: a link between bone and vascular disease.

Authors:  Annamaria Bruzzese; Antonio Lacquaniti; Valeria Cernaro; Carlo Alberto Ricciardi; Saverio Loddo; Adolfo Romeo; Gaetano Montalto; Giuseppe Costantino; Francesco Torre; Giuseppina Pettinato; Ignazio Salamone; Carmela Aloisi; Domenico Santoro; Michele Buemi
Journal:  Ren Fail       Date:  2016-03-22       Impact factor: 2.606

Review 6.  Contribution of bone and mineral abnormalities to cardiovascular disease in patients with chronic kidney disease.

Authors:  Paolo Raggi; Michael Kleerekoper
Journal:  Clin J Am Soc Nephrol       Date:  2008-03-05       Impact factor: 8.237

7.  Relation of age, gender, and bone mass to circulating sclerostin levels in women and men.

Authors:  Ulrike I Mödder; Kelley A Hoey; Shreyasee Amin; Louise K McCready; Sara J Achenbach; B Lawrence Riggs; L Joseph Melton; Sundeep Khosla
Journal:  J Bone Miner Res       Date:  2011-02       Impact factor: 6.741

8.  Independent association between serum sclerostin levels and carotid artery atherosclerosis in prevalent haemodialysis patients.

Authors:  Alper Kirkpantur; Mustafa Balci; Aysel Turkvatan; Baris Afsar
Journal:  Clin Kidney J       Date:  2015-08-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.